CJC-1295 in Australia
Get CJC-1295 — almost always prescribed as a 1:1 blend with Ipamorelin in Australian practice — lawfully under TGA SAS-B by an AHPRA-registered doctor. $99 initial telehealth consult, cold-chain dispense from a TGA-licensed Australian compounding pharmacy.
AHPRA-registered doctors
CJC-1295 / Ipamorelin is prescribed only after a clinical review by a registered Australian medical practitioner with baseline pathology.
TGA SAS-B pathway
CJC-1295 isn't on the ARTG, but it can be lawfully prescribed under SAS-B by an Australian doctor on a case-by-case basis.
1:1 with Ipamorelin
Standard Australian practice is a CJC-1295 / Ipamorelin blend — stronger pulsatile GH response, minimal cortisol or prolactin spillover.
What is CJC-1295?
CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH). It increases the amplitude of natural growth-hormone pulses from the pituitary. In Australian clinical practice it's almost always prescribed as a 1:1 blend with Ipamorelin — a selective ghrelin-receptor agonist that increases the frequency of those pulses. Together they produce a stronger pulsatile GH response than either alone, with minimal cortisol or prolactin spillover.
CJC-1295 (and the blend) are not on the ARTG. An AHPRA-registered Australian doctor can lawfully prescribe it under the TGA Special Access Scheme Category B (SAS-B), with the medicine compounded by a TGA-licensed Australian compounding pharmacy under PIC/S GMP. Importing it yourself from offshore vendors is not lawful.
Typical clinical indications
- Adult recovery and body-composition support
- Sleep quality and slow-wave sleep restoration
- Adjunctive to lifestyle interventions in adults 30+
- Post-training recovery in athletic populations (case-by-case)
Administration
Subcutaneous injection at bedtime, compounded as a single vial (typically 1:1 with Ipamorelin). Cycled per prescriber direction with baseline pathology — there is no universal protocol.
Cautions and contraindications
Not for use in pregnancy, breastfeeding, active cancer, or uncontrolled diabetes. Baseline pathology (fasting glucose, HbA1c, IGF-1, lipid panel) is standard before starting. Discuss any pituitary or adrenal history at consult.
How to get CJC-1295 prescribed in Australia
- 1. Free 5-minute pre-qualification
Answer screening questions about your history, goals, and current medications. Instant suitability check.
- 2. $99 telehealth consult
Video or phone consult with an AHPRA-registered Australian doctor. They review eligibility and confirm dosing.
- 3. SAS-B script issued (24–48 hours)
Doctor lodges a TGA SAS-B notification and routes the script to a TGA-licensed Australian compounding pharmacy.
- 4. Cold-chain dispense (2–4 business days)
Pharmacy ships cold-chain Mon–Wed. Includes vials, syringes, alcohol swabs, and a starter guide.
Do not import CJC-1295 from overseas
Importing CJC-1295 yourself from offshore "research chemical" vendors is illegal under the Customs Act, gives no guarantee of sterility or potency, and leaves you with no Australian doctor if something goes wrong. The lawful path is AHPRA-registered doctor → TGA SAS-B → TGA-licensed Australian compounding pharmacy. See why staying local matters.
CJC-1295 Australia — FAQs
- Is CJC-1295 legal in Australia?
- Yes, when prescribed by an AHPRA-registered Australian doctor under the TGA Special Access Scheme Category B (SAS-B) and dispensed by a TGA-licensed Australian compounding pharmacy. Buying CJC-1295 from offshore 'research peptide' vendors is not legal under the Customs Act.
- Why is CJC-1295 blended with Ipamorelin?
- CJC-1295 (a GHRH analogue) increases the amplitude of GH pulses; Ipamorelin (a selective ghrelin-receptor agonist) increases their frequency. The 1:1 blend produces a stronger pulsatile GH response than either alone, with minimal cortisol or prolactin spillover — which is why it's the most commonly prescribed combination in Australian peptide practice.
- What's the difference between CJC-1295 DAC and no-DAC?
- CJC-1295 DAC (drug affinity complex) has a longer half-life (~6–8 days) and produces a sustained 'bleed' of GH. CJC-1295 no-DAC (also called Modified GRF 1-29) has a much shorter half-life (~30 minutes) and preserves the natural pulsatile GH pattern — which is why most Australian prescribers favour the no-DAC version blended with Ipamorelin.
- How long until I notice effects?
- Most patients report improved sleep quality within 1–2 weeks. Recovery and body-composition changes typically take 8–12 weeks of consistent use alongside training and nutrition.
- How much does CJC-1295 / Ipamorelin cost in Australia?
- Roughly AUD $220–$380 per month for a compounded 1:1 blend from a TGA-licensed Australian pharmacy, plus the $99 initial telehealth consult and any baseline pathology. First-month spend is typically $400–$550.
- Is CJC-1295 banned in sport?
- Yes — CJC-1295 and Ipamorelin are on the WADA Prohibited List (S2 — Peptide Hormones, Growth Factors). If you compete in WADA-tested sport, do not use them. Raise sporting-body rules with your prescriber at consult.
Related reading
Related Australian peptide pages
Start with the legality hub if you're new to TGA SAS-B prescribing, or browse the other Australian peptide landings.
- Tirzepatide AustraliaMounjaro & SAS-B weight management
- BPC-157 AustraliaTissue repair & gut-lining support
- Ipamorelin AustraliaSelective ghrelin-receptor agonist
- GHK-Cu AustraliaCopper peptide for skin & repair
- MOTS-c AustraliaMitochondrial metabolic peptide
- AOD-9604 AustraliaFat-metabolism peptide fragment
Medically reviewed by the PeptideDoctorAU Medical Review Panel — last reviewed 29 May 2026. See the panel.
Start your CJC-1295 consult — $99
Take the free 5-minute pre-qualification. If you're suitable, you'll be matched with an AHPRA-registered Australian doctor for a $99 telehealth consult — TGA SAS-B prescribing, Australian-compounded vial.
Start free assessment